Safety issues associated with proton pump inhibitors (PPIs) have recently attracted
widespread media and lay attention. Gastroenterologists are frequently asked about the …

Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …

Gastroesophageal reflux disease (GERD) is arguably the most common disease
encountered by the gastroenterologist. It is equally likely that the primary care providers will …

Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for
treatment of acid-related diseases including gastroesophageal reflux disease and …

To identify the relationship between proton-pump inhibitors (PPIs) and the risk of fracture, we
conducted an update meta-analysis of observational studies. Results showed that PPI use …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) can eradicate dysplasia and
intestinal metaplasia in patients with dysplastic Barrett's esophagus (BE), and reduce rates …

OBJECTIVES: Proton pump inhibitors (PPIs) are widely used in several acid-related
gastrointestinal disorders. In vivostudies have suggested that gastric suppression by PPIs …

Proton pump inhibitors have an excellent safety profile and have become one of the most
commonly prescribed class of drugs in primary and specialty care. Long-term, sometimes …

Drug-induced osteoporosis is a significant health problem and many physicians are
unaware that many commonly prescribed medications contribute to significant bone loss …

We performed a meta-analysis of relevant studies to quantify the magnitude of the
association between proton pump inhibitors (PPIs) and risk of hip fracture. Patients with PPIs …